(IBLC) Blockchain Tech - Overview
Etf: Blockchain, Tech, ETF, Securities, Derivatives
Dividends
| Dividend Yield | 6.07% |
| Yield on Cost 5y | 12.10% |
| Yield CAGR 5y | 218.35% |
| Payout Consistency | 90.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 80.2% |
| Relative Tail Risk | -4.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.47 |
| Alpha | -12.08 |
| Character TTM | |
|---|---|
| Beta | 2.005 |
| Beta Downside | 1.694 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.68% |
| CAGR/Max DD | 0.85 |
Description: IBLC Blockchain Tech December 22, 2025
The iShares Blockchain and Tech ETF (NYSE ARCA: IBLC) is a U.S.–registered equity fund that must allocate at least 80% of its net assets to the securities comprising its underlying index or to assets that are “substantially identical” to those securities. The remaining 20% may be placed in futures, options, swaps, cash, or cash equivalents, making the fund non-diversified and potentially more sensitive to the performance of its core holdings.
As of the latest filing (Q3 2024), IBLC carries an expense ratio of 0.65% and manages roughly $210 million in assets, with the top five holdings-primarily firms engaged in blockchain infrastructure, cryptocurrency mining, and decentralized finance platforms-accounting for about 35% of the portfolio. Key sector drivers include the growth of global crypto market capitalization (which rose ~12% YoY to $2.4 trillion) and increasing institutional adoption of blockchain solutions, while regulatory developments in the U.S. and EU remain the primary source of upside/downside uncertainty.
If you’re looking to deepen your analysis, ValueRay offers a granular breakdown of IBLC’s exposure and risk metrics that can help you assess whether the fund aligns with your risk-return objectives.
What is the price of IBLC shares?
Over the past week, the price has changed by -10.80%, over one month by -16.34%, over three months by -28.06% and over the past year by +15.81%.
Is IBLC a buy, sell or hold?
What are the forecasts/targets for the IBLC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 56.8 | 47.8% |
IBLC Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 84.2m USD (84.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 84.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 84.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 13.30% (E(84.2m)/V(84.2m) * Re(13.30%) + (debt-free company))
Discount Rate = 13.30% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)